Literature DB >> 21193038

Associations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentrations in premenopausal women in the United States.

Mellissa Yong1, Stephen M Schwartz, Charlotte Atkinson, Karen W Makar, Sushma S Thomas, Frank Z Stanczyk, Kim C Westerlind, Katherine M Newton, Victoria L Holt, Wendy M Leisenring, Johanna W Lampe.   

Abstract

Glucuronidation, catalyzed by UDP-glucuronosyltransferases (UGT) and sulfation, catalyzed by sulfotransferases (SULT), are pathways through which sex steroids are metabolized to less active compounds. These enzymes are highly polymorphic and genetic variants frequently result in higher or lower activity. The phenotypic effects of these polymorphisms on circulating sex steroids in premenopausal women have not yet been investigated. One hundred and seventy women aged 40-45 years had a blood sample drawn during the follicular phase of the menstrual cycle for sex steroid measures and to obtain genomic DNA. Urine was collected for 2-hydroxy (OH) estrone (E(1)) and 16α-OH E(1) measures. Generalized linear regression models were used to assess associations between sex steroids and polymorphisms in the UGT1A and UGT2B families, SULT1A1, and SULT1E1. Women with the UGT1A1(TA7/TA7) genotype had 25% lower mean estradiol (E(2)) concentrations compared to the wildtype (TA6/TA6) (p=0.02). Similar associations were observed between SULT1A1(R213/H213) and E(1) (13% lower mean E(1) concentration vs. wildtype; p-value=0.02) and UGT2B4(E458/E458) and dehydroepiandrosterone (DHEA) (20% lower mean DHEA vs. wildtype; p-value=0.03). The SULT1E1(A/C) and the UGT1A1(TA7)-UGT1A3(R11) haplotypes were associated with reduced estrogen concentrations. Further study of UGT and SULT polymorphisms and circulating sex steroid measures in larger populations of premenopausal women is warranted.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193038      PMCID: PMC3065887          DOI: 10.1016/j.jsbmb.2010.12.014

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  49 in total

1.  Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects.

Authors:  E J Carlini; R B Raftogianis; T C Wood; F Jin; W Zheng; T R Rebbeck; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  2001-02

2.  The optimal timing of blood collection during the menstrual cycle for the assessment of endogenous sex hormones: can interindividual differences in levels over the whole cycle be assessed on a single day?

Authors:  Naseer Ahmad; Tessa M Pollard; Nigel Unwin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

3.  Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.

Authors:  C Guillemette; I De Vivo; S E Hankinson; C A Haiman; D Spiegelman; D E Housman; D J Hunter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

4.  Breast imaging reporting and data system (BI-RADS).

Authors:  Laura Liberman; Jennifer H Menell
Journal:  Radiol Clin North Am       Date:  2002-05       Impact factor: 2.303

5.  Catecholestrogen sulfation: possible role in carcinogenesis.

Authors:  Araba A Adjei; Richard M Weinshilboum
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

Review 6.  Hormonal carcinogenesis.

Authors:  B E Henderson; H S Feigelson
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

Review 7.  Polycystic ovary syndrome: an endocrine and metabolic disease.

Authors:  A M Scarpitta; D Sinagra
Journal:  Gynecol Endocrinol       Date:  2000-10       Impact factor: 2.260

8.  Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians.

Authors:  Christoph Köhle; Bernd Möhrle; Peter A Münzel; Matthias Schwab; Dorothee Wernet; Osama A Badary; Karl Walter Bock
Journal:  Biochem Pharmacol       Date:  2003-05-01       Impact factor: 5.858

9.  Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

Authors:  Takashi Suzuki; Taisuke Nakata; Yasuhiro Miki; Chika Kaneko; Takuya Moriya; Takanori Ishida; Shiro Akinaga; Hisashi Hirakawa; Michio Kimura; Hironobu Sasano
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

10.  Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States.

Authors:  Charlotte Atkinson; Katherine M Newton; Frank Z Stanczyk; Kim C Westerlind; Lin Li; Johanna W Lampe
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

View more
  8 in total

1.  The relation of urinary estrogen metabolites with mammographic densities in premenopausal women.

Authors:  Gertraud Maskarinec; Sreang Heak; Yukiko Morimoto; Laurie Custer; Adrian A Franke
Journal:  Cancer Epidemiol       Date:  2012-04-25       Impact factor: 2.984

2.  Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.

Authors:  Thomas P Ahern; Mariann Christensen; Deirdre P Cronin-Fenton; Kathryn L Lunetta; Håvard Søiland; Jennifer Gjerde; Jens Peter Garne; Carol L Rosenberg; Rebecca A Silliman; Henrik Toft Sørensen; Timothy L Lash; Stephen Hamilton-Dutoit
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

3.  Lack of association between the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene polymorphism and the risk of benign prostatic hyperplasia in Caucasian men.

Authors:  Anastasios Karatzas; Vassilios Tzortzis; Eirini Giannatou; Stavros Gravas; Ioannis Zachos; Athanassios Oeconomou; Michael Melekos; Aspasia Tsezou
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

4.  Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.

Authors:  Dominique Scherer; Lisel M Koepl; Elizabeth M Poole; Yesilda Balavarca; Liren Xiao; John A Baron; Li Hsu; Anna E Coghill; Peter T Campbell; Sarah E Kleinstein; Jane C Figueiredo; Johanna W Lampe; Katharina Buck; John D Potter; Richard J Kulmacz; Mark A Jenkins; John L Hopper; Aung K Win; Polly A Newcomb; Cornelia M Ulrich; Karen W Makar
Journal:  Genes Chromosomes Cancer       Date:  2014-03-28       Impact factor: 5.006

5.  An automated magnetic bead extraction method for measuring plasma metanephrines and 3-methoxytyramine using liquid chromatography tandem mass spectrometry.

Authors:  Songlin Yu; Weiyan Zhou; Jialei Yu; Ming Li; Shenyan Zhang; Xu Jiang; Huanhong Wang; Xiaoli Ma; Yutong Zou; Danchen Wang; Qian Cheng; Shaowei Xie; Wei Luo; Xiuzhi Guo; Ling Qiu
Journal:  Anal Bioanal Chem       Date:  2022-03-02       Impact factor: 4.478

6.  Reliability of a dried urine test for comprehensive assessment of urine hormones and metabolites.

Authors:  Mark Newman; Desmond A Curran
Journal:  BMC Chem       Date:  2021-03-15

7.  Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users.

Authors:  Merete Ellingjord-Dale; Eunjung Lee; Elisabeth Couto; Ali Ozhand; Samera Qureshi; Solveig Hofvind; David J Van Den Berg; Lars A Akslen; Tom Grotmol; Giske Ursin
Journal:  Breast Cancer Res       Date:  2012-10-27       Impact factor: 6.466

8.  Hydroxylation and sulfation of sex steroid hormones in inflammatory liver.

Authors:  Sang R Lee; Seung-Yeon Lee; Sang-Yun Kim; Si-Yun Ryu; Bae-Kuen Park; Eui-Ju Hong
Journal:  J Biomed Res       Date:  2017-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.